ERBB2 and breast cancer: According to our analysis, the overexpression of PBK/TOPK in luminal A was significantly lower than that of HER-2(+) and TNBC types, which once again confirmed that PBK/TOPK overexpression is associated with a worse prognosis for breast cancer.